Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19
In retrospective study, hospitalized patients who got antibiotics seemed to do slightly worse
Related Articles
HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable…
Regulators Approve Lenacapavir for H.I.V. Prevention
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in…
HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable…
Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis
These findings must be weighed against the drug’s established efficacy in this disease
Ebola and a Decade of Disparities — Forging a Future for Global Health Equity | NEJM
Since the 2014–2016 West African Ebola outbreak, there have been numerous proposals and promises to reform global health infrastructure. Yet inequity remains deeply entrenched.
Cytomegalovirus reactivates in significant proportion of COVID-19 patients
30.6% of ICU patients experienced CMV reactivation.
Analysis highlights bacterial contamination, multidrug-resistance, in retail meat samples
An analysis of FDA data found over one-third of US retail meat samples tested positive for potentially harmful bacteria, and nearly 1 in 4 bacterial…
States with links to West Texas measles outbreak announce more cases
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 In a large measles outbreak centered in West Texas, Texas and other states with linked cases—Kansas and Oklahoma — have…
ACIP draft agenda revives anti-vaccine boilerplate topics
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 In closely watched developments ahead of next week’s meeting of the Centers for Disease Control and Prevention (CDC) vaccine advisory…